Paratek Pharmaceuticals Inc.

NASDAQ:PRTK   10:13:13 AM EDT
5.12
-0.03 (-0.58%)
Products

Paratek Pharmaceuticals Announces FDA Orphan Drug Designation For Nuzyra For The Treatment Of Infections Caused By Nontuberculous Mycobacteria

Published: 08/18/2021 20:46 GMT
Paratek Pharmaceuticals Inc. (PRTK) - Paratek Pharmaceuticals Announces FDA Orphan Drug Designation for Nuzyra® (omadacycline) for the Treatment of Infections Caused by Nontuberculous Mycobacteria.